Effects on Blood Pressure of the -Glucosidase Inhibitor Acarbose Compared with the Insulin Enhancer Glibenclamide in Patients with Hypertension and Type 2 Diabetes Mellitus

Author： Rosenthal J.H.   Mauersberger H.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.22, Iss.10, 2002-01, pp. : 695-701

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of the Potential Clinical and Economic Effects of Bodyweight Stabilisation with Acarbose in Patients with Type 2 Diabetes Mellitus: A Decision-Analytical Approach

By Banz K.  

PharmacoEconomics, Vol. 13, Iss. 4, 1998-04 ,pp. : 449-459

Adis International

Access to resources Recommend Favorite

Postmarketing Surveillance of Acarbose Treatment in Taiwanese Patients with Type 2 Diabetes Mellitus

By Hung Yi-Jen  

Clinical Drug Investigation, Vol. 26, Iss. 10, 2006-01 ,pp. : 559-565

Adis International

Access to resources Recommend Favorite

Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes Mellitus

By Britton M.E.   denver A.E.   Mohamed-Ali V.   Yudkin J.S.  

Clinical Drug Investigation, Vol. 16, Iss. 4, 1998-10 ,pp. : 303-317

Adis International

Access to resources Recommend Favorite

Treatment with rosiglitazone reduces ambulatory BP and increases insulin sensitivity in patients with hypertension and type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1458, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Acarbose in the Treatment of Type 1 and Type 2 Diabetes Mellitus

By Neuser Dieter  

Clinical Drug Investigation, Vol. 25, Iss. 9, 2005-01 ,pp. : 579-587

Adis International

Access to resources Recommend Favorite